NPPB and heart failure: While the CONUT score has demonstrated prognostic significance across numerous studies, B-type natriuretic peptide (BNP) continues to serve as the most established biomarker for evaluating risk and guiding therapy in heart failure, due to its direct association with disease severity and its integral role in patient management.